Opinion Instead of blindly reducing list prices for all drugs we should instead seek solutions that assess every treatment in the context of its value to individual patients and the downstream savings they may facilitate elsewhere. httpsbuff.ly32L5J
Opinion: Instead of blindly reducing list prices for all drugs, we should instead seek solutions that assess every treatment in the context of its value to individual patients and the downstream savings they may facilitate elsewhere. https://buff.ly/32L5J
23:00 EDT 18 Jul 2019 |
STAT
More From BioPortfolio on "Opinion: Instead of blindly reducing list prices for all drugs, we should instead seek solutions that assess every treatment in the context of its value to individual patients and the downstream savings they may facilitate elsewhere. https://buff.ly/32L5J"